Lv4
470 积分 2023-09-26 加入
Survival of induction aumolertinib followed by aumolertinib and concurrent radiotherapy (RT) in unresectable EGFR -mutated stage III NSCLC: Final analysis of the phase III ADVANCE trial and real-world data
18小时前
待确认
Immune-related generalised oedema – A new category of adverse events with immune checkpoint inhibitors
1个月前
已完结
Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non–Small Cell Lung Cancer Patients
5个月前
已完结
Durvalumab Plus Concurrent Radiotherapy for Treatment of Locally Advanced Non–Small Cell Lung Cancer
5个月前
已完结
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
5个月前
已完结
Recent Advances in the Treatment of Melanoma
5个月前
已完结
Immune checkpoint inhibitor–associated capillary leak syndrome: A systematic review and a worldwide pharmacovigilance study
5个月前
已完结
A deep learning MR-based radiomic nomogram may predict survival for nasopharyngeal carcinoma patients with stage T3N1M0
1年前
已完结
DevelopmentandValidation ofanAutomatedImage-BasedDeepLearning Platform for Sarcopenia Assessment in HeadandNeckCancer
2年前
已关闭
Assessment of Artificial Intelligence Chatbot Responses to Top Searched Queries About Cancer
2年前
已完结
女性生育力及其影响因素
2年前
已采纳
皖公网安备34019202002308
